Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02470988
Other study ID # 15/WS/0027
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 2015
Est. completion date December 2016

Study information

Verified date June 2021
Source University of Edinburgh
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to investigate the process of symptom change in Cognitive Behavioural Analysis System of Psychotherapy (CBASP), and how the individual components of the therapy affect this change in individuals with chronic depression.


Description:

A form of psychotherapy called Behaviour Analysis System of Psychotherapy (CBASP) has been developed specifically to treat individuals suffering from chronic, long-standing depression. There is a growing evidence base to suggest that CBASP is effective for these individuals, especially when combined with anti-depressant medication. This evidence comes from case series and randomised controlled trials that have compared CBASP with other forms of therapy such as Interpersonal Psychotherapy and Cognitive Behaviour Therapy, and with medication. The evidence from these studies consistently shows CBASP to be effective, and it compares favourably with other forms of therapy. Given these findings, it is important to understand how change happens in CBASP and how it is affected by the components of the therapy. Understanding how individuals experience change within CBASP will have important implications for how the therapy is delivered in the future. For example if change is found to be non-linear it would be important to understand what components of the therapy are associated with improvement. There could also be organisational implications, for example relating to the optimal number of sessions to offer in order to achieve acceptable change while balancing therapist time. The proposed study aims to investigate the process of psychological change in CBASP. This will be done by providing CBASP to a small number of individuals and gathering outcome data (rating of mood) at every therapy appointment. Session--by-session change will then be mapped for each participant. The study will include two arms: CBASP; and CBASP without Disciplined Personal Involvement (DPI). DPI involves specifically using the therapist--client relationship to help the client to discriminate between previous maladaptive relationships and other, positive ones. The reason for including this condition is to investigate whether DPI affects the process of psychological change in CBASP, as it is a unique feature of the therapy. The study will use a single-case design, as the aim is to map change within each individual participant in the context of the therapy. This design was deemed appropriate as the study does not aim to make claims about the overall effectiveness of CBASP, but to provide an analysis of individual psychological change for participants receiving CBASP.


Recruitment information / eligibility

Status Completed
Enrollment 13
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 64 Years
Eligibility Inclusion Criteria: - Aged between 18 and 64 years, inclusive - Have been depressed for 2 years or longer - Have had previous episodes of depression - Previous treatment (medication, psychotherapy or both) unsuccessful or participant has relapsed - Do not meet any of the exclusion criteria - Able to provide informed consent to participate in the study Exclusion Criteria: - Received psychological therapy in previous 12 months - Current significant substance misuse - Presence of learning difficulties - Presence of psychosis - Unable to commit to the full duration of the study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive Behavioural Analysis System of Psychotherapy

CBASP Without DPI


Locations

Country Name City State
United Kingdom NHS Tayside Dundee
United Kingdom NHS Lothian Edinburgh

Sponsors (1)

Lead Sponsor Collaborator
University of Edinburgh

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient Health Questionnaire - 9 (PHQ-9) Administered at three weekly baseline assessments and then at every therapy session for all participants over a period of 6 months or up to 20 sessions. 6 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT00596986 - Getting Biased Treatment Study: How Psychotherapy and Antidepressants Change Brain Activity in Chronic Depression N/A
Completed NCT05221567 - Intensive Psychotherapy for Chronic Depression N/A
Recruiting NCT00837564 - Cognitive Behavioural Analysis System of Psychotherapy (CBASp) Versus Escitalopram in Chronic Depression Phase 3
Completed NCT00006172 - Clinical Trials of Two Non-drug Treatments for Chronic Depression N/A
Recruiting NCT05833087 - Schema Therapy for Patients With Chronic Treatment Resistant Depression N/A